0001171843-18-006626.txt : 20180919 0001171843-18-006626.hdr.sgml : 20180919 20180919152115 ACCESSION NUMBER: 0001171843-18-006626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180402 FILED AS OF DATE: 20180919 DATE AS OF CHANGE: 20180919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Islam Khalid CENTRAL INDEX KEY: 0001701858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 181077705 MAIL ADDRESS: STREET 1: C/O IMMUNOMEDICS, INC. STREET 2: 300 THE AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 ownership.xml X0306 4 2018-04-02 0 0000722830 IMMUNOMEDICS INC IMMU 0001701858 Islam Khalid C/O IMMUNOMEDICS, INC 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 0 0 0 Common Stock, $0.01 par value per share 2018-04-02 4 A 0 3849 0 A 3849 D Stock Options (right to buy) 14.29 2018-04-02 4 A 0 6497 0.0 A 2019-04-02 2025-04-02 Common Stock, par value $0.01 per share 6497 6497 D Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018. Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer. The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer. /s/ Khalid Islam 2018-09-18